It has been reported that NR0B2 expression affects the innate immune response in liver cancer, where a partial but significant correlation between lower NR0B2 expression levels and a higher tumor infiltration of B cells and CD8+ T cells has been found [3]. Here, CD8A is linked to liver cancer.